These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11488091)

  • 1. Adverse events following yellow fever vaccination.
    Wkly Epidemiol Rec; 2001 Jul; 76(29):217-8. PubMed ID: 11488091
    [No Abstract]   [Full Text] [Related]  

  • 2. The US-Certified Yellow Fever Vaccination Center Registry: a tool for travelers, state health departments, and vaccine providers.
    Russell MN; Cetron MS; Eidex RB
    J Travel Med; 2006; 13(1):48-9. PubMed ID: 16412108
    [No Abstract]   [Full Text] [Related]  

  • 3. Neurological adverse events temporally associated to mass vaccination against yellow fever in Juiz de Fora, Brazil, 1999-2005.
    Fernandes GC; Camacho LA; Sá Carvalho M; Batista M; de Almeida SM
    Vaccine; 2007 Apr; 25(16):3124-8. PubMed ID: 17316927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yellow fever: epidemiology and prevention.
    Barnett ED
    Clin Infect Dis; 2007 Mar; 44(6):850-6. PubMed ID: 17304460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-related risk of adverse events following yellow fever vaccination in Australia.
    Lawrence GL; Burgess MA; Kass RB
    Commun Dis Intell Q Rep; 2004; 28(2):244-8. PubMed ID: 15460963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First case of yellow fever vaccine-associated viscerotropic disease (YEL-AVD) in Hong Kong.
    Leung WS; Chan MC; Chik SH; Tsang TY
    J Travel Med; 2016 Apr; 23(4):. PubMed ID: 27087559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of yellow fever vaccine in Indian travellers: A prospective observational study.
    Tiwari P; Ahlawat R; Gupta G
    Indian J Med Res; 2016 Nov; 144(5):778-780. PubMed ID: 28361832
    [No Abstract]   [Full Text] [Related]  

  • 8. Yellow fever vaccination and neurological complications.
    Bayão TS; Cupertino MDC; Gomes AP; Siqueira-Batista R
    Rev Soc Bras Med Trop; 2018; 51(5):723-724. PubMed ID: 30304289
    [No Abstract]   [Full Text] [Related]  

  • 9. The revised global yellow fever risk map and recommendations for vaccination, 2010: consensus of the Informal WHO Working Group on Geographic Risk for Yellow Fever.
    Jentes ES; Poumerol G; Gershman MD; Hill DR; Lemarchand J; Lewis RF; Staples JE; Tomori O; Wilder-Smith A; Monath TP;
    Lancet Infect Dis; 2011 Aug; 11(8):622-32. PubMed ID: 21798462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rarity of adverse effects after 17D yellow-fever vaccination.
    Marianneau P; Georges-Courbot M; Deubel V
    Lancet; 2001 Jul; 358(9276):84-5. PubMed ID: 11463403
    [No Abstract]   [Full Text] [Related]  

  • 11. Yellow fever vaccination: some thoughts on how much is enough [Vaccine 23 (2005) 3908-3914].
    Martins RM; Galler R; Freire MS; Camacho LA; de Lourdes S Maia M; Homma A
    Vaccine; 2007 Jan; 25(1):10-1. PubMed ID: 16448728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Yellow fever virus transmission via breastfeeding: follow-up to the paper on breastfeeding travelers.
    Chen LH; Zeind C; Mackell S; LaPointe T; Mutsch M; Wilson ME
    J Travel Med; 2010; 17(4):286-7. PubMed ID: 20636609
    [No Abstract]   [Full Text] [Related]  

  • 13. Yellow fever vaccine. WHO position paper.
    World Health Organization
    Wkly Epidemiol Rec; 2003 Oct; 78(40):349-59. PubMed ID: 14569711
    [No Abstract]   [Full Text] [Related]  

  • 14. Yellow fever vaccine-associated viscerotropic disease and death in Spain.
    Doblas A; Domingo C; Bae HG; Bohórquez CL; de Ory F; Niedrig M; Mora D; Carrasco FJ; Tenorio A
    J Clin Virol; 2006 Jun; 36(2):156-8. PubMed ID: 16597510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy and safety of vaccination against yellow fever of persons traveling to endemic areas].
    Dabrowska MM; Flisiak R
    Przegl Epidemiol; 2010; 64(2):319-22. PubMed ID: 20731245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case suspected for yellow fever vaccine-associated viscerotropic disease in the Netherlands.
    van de Pol EM; Gisolf EH; Richter C
    J Travel Med; 2014; 21(6):421-4. PubMed ID: 24920138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Yellow fever vaccines and international travelers.
    Barnett ED; Wilder-Smith A; Wilson ME
    Expert Rev Vaccines; 2008 Jul; 7(5):579-87. PubMed ID: 18564013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Yellow fever and Japanese encephalitis vaccines: indications and complications.
    Marfin AA; Eidex RS; Kozarsky PE; Cetron MS
    Infect Dis Clin North Am; 2005 Mar; 19(1):151-68, ix. PubMed ID: 15701552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Staples JE; Gershman M; Fischer M;
    MMWR Recomm Rep; 2010 Jul; 59(RR-7):1-27. PubMed ID: 20671663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Yellow fever].
    Wiercińska-Drapało A
    Przegl Epidemiol; 2004; 58 Suppl 1():101-5. PubMed ID: 15807166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.